Unknown

Dataset Information

0

Lower Vitamin B12 Level at Multiple System Atrophy Diagnosis Is Associated With Shorter Survival.


ABSTRACT:

Background

Multiple system atrophy (MSA) is a neurodegenerative disorder from α-synuclein aggregation. in vitro studies suggest vitamin B12 may interrupt α-synuclein-mediated neurodegeneration. The objective of this study was to determine whether serum vitamin B12 level at MSA diagnosis is associated with survival.

Methods

One hundred eighty-two MSA patients evaluated at Mayo Clinic with vitamin B12 testing were studied. We determined the risk of death in relationship to serum vitamin B12 levels at MSA diagnosis, adjusting for predictors of poor survival.

Results

Predictors of shorter survival included vitamin B12 < 367 ng/L (HR, 1.8; 95% CI, 1.3-2.7), falls within 3 years of MSA diagnosis (HR, 1.6; 95% CI, 1.1-2.3), bladder symptoms (HR, 1.6; 95% CI, 1.0-2.6), urinary catheter requirement (HR, 1.7; 95% CI, 1.0-2.8), male sex (HR, 1.4; 95% CI, 1.0-2.0), and MSA-P subtype (HR, 1.5; 95% CI, 1.0-2.0).

Conclusions

Low vitamin B12 levels are associated with shorter survival in MSA. Additional studies to explore this observation and assess the potential role of vitamin B12 as a modifiable survival factor are needed. © 2020 International Parkinson and Movement Disorder Society.

SUBMITTER: McCarter SJ 

PROVIDER: S-EPMC7729983 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lower Vitamin B12 Level at Multiple System Atrophy Diagnosis Is Associated With Shorter Survival.

McCarter Stuart J SJ   Coon Elizabeth A EA   Savica Rodolfo R   St Louis Erik K EK   Bower James H JH   Benarroch Eduardo E EE   Sandroni Paola P   Low Phillip P   Singer Wolfgang W  

Movement disorders : official journal of the Movement Disorder Society 20200422 8


<h4>Background</h4>Multiple system atrophy (MSA) is a neurodegenerative disorder from α-synuclein aggregation. in vitro studies suggest vitamin B12 may interrupt α-synuclein-mediated neurodegeneration. The objective of this study was to determine whether serum vitamin B12 level at MSA diagnosis is associated with survival.<h4>Methods</h4>One hundred eighty-two MSA patients evaluated at Mayo Clinic with vitamin B12 testing were studied. We determined the risk of death in relationship to serum vit  ...[more]

Similar Datasets

| S-EPMC4546375 | biostudies-literature
| S-EPMC9583150 | biostudies-literature
| S-EPMC4553811 | biostudies-literature
| S-EPMC9849558 | biostudies-literature
| S-EPMC2770582 | biostudies-literature
| S-EPMC4840547 | biostudies-literature
| S-EPMC9536910 | biostudies-literature
| S-EPMC10986063 | biostudies-literature
| S-EPMC8776861 | biostudies-literature
| S-EPMC9613998 | biostudies-literature